At the news
? BEARISHIMPACT 7/10 8-K filed May 1, 2026 at 09:23 ET
Shuttle Pharmaceuticals entered into a merger agreement with United Dogecoin Inc., a dogecoin mining company, and concurrently raised $11M through a PIPE offering of Series B-2 Convertible Preferred Stock and warrants. The transaction represents a transformative shift from pharmaceuticals to crypto mining, but existing SHPH shareholders face massive dilution as the merger consideration grants United Dogecoin holders 75.65% of the pro forma equity on an as-converted basis.
- Entry into Merger Agreement with United Dogecoin Inc., a dogecoin mining company
- PIPE offering of $11M in Series B-2 Convertible Preferred Stock plus warrants for 100% warrant coverage at $1.03 per share
- Merger consideration: United Dogecoin stockholders receive 75.65% of the combined entity on an as-converted basis, excluding PIPE shares
- Up to 32.6M additional milestone shares issuable for achieving mining rig purchase, uptime, and power cost targets
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access